NCT04105517View on ClinicalTrials.gov

Hemangiol, Post Marketing Surveillance Study

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

October 20, 2019

Study Completion Date

October 30, 2019

Conditions
Infantile Hemangioma
Trial Locations (1)

34295

Uh Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04105517 - Hemangiol, Post Marketing Surveillance Study | Biotech Hunter | Biotech Hunter